These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1786989)

  • 1. A possible site of in vivo action of cyclosporin A for transplantation immunity: comparative study with cyclophosphamide.
    Hasegawa Y; Isobe K; Nagase F; Shimokata K; Nakashima I
    Immunobiology; 1991 Nov; 183(5):408-17. PubMed ID: 1786989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of alloreactive natural killer cells is resistant to cyclosporine.
    Petersson E; Qi Z; Ekberg H; Ostraat O; Dohlsten M; Hedlund G
    Transplantation; 1997 Apr; 63(8):1138-44. PubMed ID: 9133476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human in vivo cytotoxic T lymphocyte generation by cyclosporine following organ transplantation.
    Keown PA; Essery-Rice G; Hellstrom A; Sinclair NR; Stiller CR
    Transplantation; 1985 Jul; 40(1):45-9. PubMed ID: 3892796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection.
    Freed BM; Bennett JA; Rosano TG; Brooks CA; Cramer SM; Lempert N
    Transplantation; 1992 Feb; 53(2):456-60. PubMed ID: 1738941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts.
    Norin AJ; Kamholz SL
    Transplantation; 1989 Nov; 48(5):856-62. PubMed ID: 2530670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of cytolytic T lymphocytes.
    Moscovitch M; Grossman Z; Rosen D; Berke G
    Cell Immunol; 1986 Oct; 102(1):52-67. PubMed ID: 3492278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
    Cleven HA; Genden EM; Moran TM
    Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma.
    Horvath-Arcidiacono JA; Mostowski HS; Bloom ET
    Int Immunol; 1996 May; 8(5):661-73. PubMed ID: 8671653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine.
    Zhan X; Brown B; Slobod KS; Hurwitz JL
    Transplantation; 2003 Aug; 76(4):739-40. PubMed ID: 12973121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection.
    Qian JH; Kokudo S; Sato S; Hamaoka T; Fujiwara H
    Transplantation; 1987 Apr; 43(4):538-43. PubMed ID: 3495052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of the transplantation immunity of mice for rejecting ascitic allogeneic tumors.
    Ando K; Hasegawa T; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Kawashima K; Kato N; Ohashi K
    Dev Comp Immunol; 1985; 9(4):701-8. PubMed ID: 3878806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
    Van Gool SW; de Boer M; Ceuppens JL
    J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.